Literature DB >> 3947383

Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents.

J J Sheets, J I Mason, C A Wise, R W Estabrook.   

Abstract

The imidazole antimycotic agents ketoconazole, miconazole and clotrimazole were tested for their abilities to inhibit the reactions involved in the oxidative metabolism of androst-4-ene-3,17-dione by rat liver microsomal cytochromes P-450. All three compounds were found to function as potent inhibitors of steroid hydroxylase reactions, producing 50% inhibition of 6 beta-, 16 beta-, and 16 alpha-hydroxylase activities at concentrations between 10(-7) and 10(-5) M. The antimycotic agents, when added to liver microsomes, bound to cytochrome P-450 with high affinity to produce a "type II" spectral complex. These agents showed differential inhibition of the various steroid hydroxylases and were found not to affect the activities of the liver microsomal steroid 5 alpha-reductase or the androst-4-ene-3,17-dione 17-oxidoreductase. The results presented demonstrate an interaction of these imidazole antimycotic agents with the various cytochromes P-450 of liver microsomes, resulting in selective inhibition of monooxygenase activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947383     DOI: 10.1016/0006-2952(86)90224-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  SK & F 96365 inhibits carbachol-induced phosphoinositide turnover in human neuroblastoma SH-SY5Y and rat cerebellar granule cells.

Authors:  W W Lin; C W Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

2.  Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.

Authors:  T Tiffert; H Ginsburg; M Krugliak; B C Elford; V L Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  On the inhibition of prostanoid formation by SK&F 96365, a blocker of receptor-operated calcium entry.

Authors:  H J Leis; D Zach; E Huber; L Ziermann; H Gleispach; W Windischhofer
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

4.  Distinct forms of cytochrome P-450 are responsible for 6 beta-hydroxylation of bile acids and of neutral steroids.

Authors:  P Zimniak; E J Holsztynska; A Radominska; M Iscan; R Lester; D J Waxman
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  Clotrimazole inhibits the recombinant human cardiac L-type Ca2+ channel alpha 1C subunit.

Authors:  I M Fearon; S G Ball; C Peers
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells.

Authors:  Y F Xiao; L Huang; J P Morgan
Journal:  J Physiol       Date:  1998-05-01       Impact factor: 5.182

7.  The antifungal antibiotic clotrimazole potently inhibits L-type calcium current in guinea-pig ventricular myocytes.

Authors:  G P Thomas; M Karmazyn; A C Zygmunt; C Antzelevitch; N Narayanan
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

8.  Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.

Authors:  D J Back; P Stevenson; J F Tjia
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

9.  Effect of clotrimazole on the pump cycle of the Na,K-ATPase.

Authors:  Gianluca Bartolommei; Nadège Devaux; Francesco Tadini-Buoninsegni; Mariarosa Moncelli; Hans-Jürgen Apell
Journal:  Biophys J       Date:  2008-05-09       Impact factor: 4.033

10.  In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.

Authors:  D J Back; J F Tjia; J Karbwang; J Colbert
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.